scholarly journals Molecular docking and structure-based virtual screening studies of potential drug target, CAAX prenyl proteases, of Leishmania donovani

2016 ◽  
Vol 34 (11) ◽  
pp. 2367-2386 ◽  
Author(s):  
Shalini Singh ◽  
Sitrarasu Vijaya Prabhu ◽  
Venkatesan Suryanarayanan ◽  
Ruchika Bhardwaj ◽  
Sanjeev Kumar Singh ◽  
...  

2011 ◽  
Vol 8 (4) ◽  
pp. 363-370 ◽  
Author(s):  
Lakshminarayanan Karthik ◽  
Palayam Malathy ◽  
Annie Trinitta ◽  
Krishnasamy Gunasekaran


2020 ◽  
Vol 27 (12) ◽  
pp. 3327-3333
Author(s):  
Jesudass Joseph Sahayarayan ◽  
Kulanthaivel Soundar Rajan ◽  
Mutharasappan Nachiappan ◽  
Dhamodharan Prabhu ◽  
Ravi Guru Raj Rao ◽  
...  


2010 ◽  
Vol 396 (4) ◽  
pp. 985-999 ◽  
Author(s):  
James A. Brannigan ◽  
Barbara A. Smith ◽  
Zhiyong Yu ◽  
Andrzej M. Brzozowski ◽  
Michael R. Hodgkinson ◽  
...  


Author(s):  
Farah Shahid ◽  
Youssef Saeed Alghamdi ◽  
Mutaib Mashraqi ◽  
Mohsin Khurshid ◽  
Usman Ali Ashfaq




2014 ◽  
Vol 66 ◽  
pp. 14-23 ◽  
Author(s):  
Neeradi Dinesh ◽  
Dheeraj Sree Ram Pallerla ◽  
Preet Kamal Kaur ◽  
Neerupudi Kishore Babu ◽  
Sushma Singh


2015 ◽  
Vol 34 ◽  
pp. 70-77
Author(s):  
K. Zaveri ◽  
A. Krishna Chaitanya ◽  
I. Bhaskar Reddy

In recent years, insilico approaches have been predicting novel drug targets. The present day development in pharmaceutics mainly ponders on target based drugs and this has been aided by structure based drug designing and subtractive genomics. In the present study, the computational genome subtraction methodology was applied for identification of novel, potential drug target against Bacillus anthracis, cause of deadly anthrax. The potential drug target identified through subtractive genomics approach was considered as polysaccharide deacetylase. By virtual screening against NCI database and Drugbank chemical libraries, two potential lead molecules were predicted. Further the potential lead molecules and target protein were subjected for docking studies using Autodock.



Author(s):  
Ning Sun ◽  
Wing-Leung Wong ◽  
Jiao Guo

The recent outbreak of coronavirus disease 2019 caused by the new coronavirus, SARS-CoV-2, has become an international emergency. Since there is no effective therapy for the treatment of this disease, drugs or vaccine that can prevent or cure the SARS-CoV-2 infection are urgently needed. The viral 3-chymotrypsin-like cysteine protease (3CLpro), which plays a key role in the replication of coronavirus, is a potential drug target for the development of anti-SARS-CoV-2 drugs. With the crystal structure of 3CLpro, we performed virtual screening from a small chemical library of a Traditional Chinese Medicine recipe- FuFang Zhenzhu Tiaozhi (FTZ). Five compounds with the best scores were screened and could be considered as potential hit compounds to be investigated further with bioassays for their anti-virus effects.





Sign in / Sign up

Export Citation Format

Share Document